These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 37183928
1. Elevated serum trimethylamine oxide levels as potential biomarker for diabetic kidney disease. Huang Y, Zhu Z, Huang Z, Zhou J. Endocr Connect; 2023 Jul 05; 12(8):. PubMed ID: 37183928 [Abstract] [Full Text] [Related]
2. Serum Trimethylamine N-oxide and the Diversity of the Intestinal Microbial Flora in Type 2 Diabetes Complicated by Diabetic Kidney Disease. Yang M, Zhang R, Zhuang C, Wu Y, Yang Q, Yu Z, Liu J, Zha B, Gong Q, Yang B, Zeng M, Yan C. Clin Lab; 2022 May 01; 68(5):. PubMed ID: 35536069 [Abstract] [Full Text] [Related]
3. Trimethylamine N-Oxide Exacerbates Renal Inflammation and Fibrosis in Rats With Diabetic Kidney Disease. Fang Q, Zheng B, Liu N, Liu J, Liu W, Huang X, Zeng X, Chen L, Li Z, Ouyang D. Front Physiol; 2021 May 01; 12():682482. PubMed ID: 34220546 [Abstract] [Full Text] [Related]
4. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease. Duan S, Chen J, Wu L, Nie G, Sun L, Zhang C, Huang Z, Xing C, Zhang B, Yuan Y. J Diabetes Complications; 2020 Oct 01; 34(10):107665. PubMed ID: 32653382 [Abstract] [Full Text] [Related]
5. Zuogui-Jiangtang-Yishen decoction prevents diabetic kidney disease: Intervene pyroptosis induced by trimethylamine n-oxide through the mROS-NLRP3 axis. Yi ZY, Peng YJ, Hui BP, Liu Z, Lin QX, Zhao D, Wang Y, Liu X, Xie J, Zhang SH, Huang JH, Yu R. Phytomedicine; 2023 Jun 01; 114():154775. PubMed ID: 36990008 [Abstract] [Full Text] [Related]
6. Increased Serum Trimethylamine N-Oxide Level in Type 2 Diabetic Patients with Mild Cognitive Impairment. Xu N, Wan J, Wang C, Liu J, Qian C, Tan H. Diabetes Metab Syndr Obes; 2022 Jun 01; 15():2197-2205. PubMed ID: 35923251 [Abstract] [Full Text] [Related]
7. Vitamin D is involved in the effects of the intestinal flora and its related metabolite TMAO on perirenal fat and kidneys in mice with DKD. Zheng X, Huang Y, Yang M, Jin L, Zhang X, Zhang R, Wu Y, Yan C, Gao Y, Zeng M, Li F, Zhou X, Zhang N, Liu J, Zha B. Nutr Diabetes; 2024 Jun 10; 14(1):42. PubMed ID: 38858392 [Abstract] [Full Text] [Related]
8. Elevated plasma trimethylamine-N-oxide levels are associated with diabetic retinopathy. Liu W, Wang C, Xia Y, Xia W, Liu G, Ren C, Gu Y, Li X, Lu P. Acta Diabetol; 2021 Feb 10; 58(2):221-229. PubMed ID: 33064205 [Abstract] [Full Text] [Related]
11. Diagnostic value of triglyceride and cystatin C ratio in diabetic kidney disease: a retrospective and prospective cohort study based on renal biopsy. Wei J, Wang B, Shen FJ, Zhang TT, Duan Z, Zhou DM. BMC Nephrol; 2022 Jul 27; 23(1):270. PubMed ID: 35896961 [Abstract] [Full Text] [Related]
12. Serum high mobility group box 1 as a potential biomarker for the progression of kidney disease in patients with type 2 diabetes. Liu T, Zhao H, Wang Y, Qu P, Wang Y, Wu X, Zhao T, Yang L, Mao H, Peng L, Zhan Y, Li P. Front Immunol; 2024 Jul 27; 15():1334109. PubMed ID: 38481996 [Abstract] [Full Text] [Related]
13. Association of Circulating Carbohydrate Antigen 19-9 Level with Type 2 Diabetic Kidney Disease in Chinese Adults: A Cross-Sectional Study. Yan P, Li J, Zhang Y, Dan X, Wu X, Zhang X, Yang Y, Chen X, Li S, Chen P, Wan Q, Xu Y. Diabetes Metab Syndr Obes; 2024 Jul 27; 17():467-477. PubMed ID: 38312210 [Abstract] [Full Text] [Related]
14. Potential Role of the Renal Arterial Resistance Index in the Differential Diagnosis of Diabetic Kidney Disease. Li H, Shen Y, Yu Z, Huang Y, He T, Xiao T, Li Y, Xiong J, Zhao J. Front Endocrinol (Lausanne); 2021 Jul 27; 12():731187. PubMed ID: 35095752 [Abstract] [Full Text] [Related]
15. Serum lutein is a promising biomarker for type 2 diabetes mellitus and diabetic kidney disease in the elderly. Pan F, Cui W, Gao L, Shi X, Yang H, Hu Y, Li M. J Clin Lab Anal; 2022 Apr 27; 36(4):e24350. PubMed ID: 35293029 [Abstract] [Full Text] [Related]
16. The correlation between serum uric acid and diabetic kidney disease in type 1 diabetes patients in Anhui, China. Jiang J, Zhou X, Lan L, Ren W. BMC Nephrol; 2023 Aug 24; 24(1):252. PubMed ID: 37612612 [Abstract] [Full Text] [Related]
17. Implications of increased circulating macrophage inhibitory protein-5 in patients with type 2 diabetes mellitus. Zhao B, Zhang M, Xie J, Jiang T, Li J, Yang Z. Int Immunopharmacol; 2022 Aug 24; 109():108916. PubMed ID: 35679662 [Abstract] [Full Text] [Related]
18. Exploration of Noninvasive Detection of Advanced Glycation End Products in the Lens to Screen for Diabetic Kidney Disease. Zhang XM, Gao Y, Yang MX, Zheng XD, Zhang R, Wu YY, Zeng M, Yang Q, Yu ZY, Liu J, Zha BB, Yang B. Front Endocrinol (Lausanne); 2022 Aug 24; 13():892070. PubMed ID: 35846309 [Abstract] [Full Text] [Related]
19. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus. Yamamoto CM, Murakami T, Oakes ML, Mitsuhashi M, Kelly C, Henry RR, Sharma K. Am J Nephrol; 2018 Aug 24; 47(5):283-291. PubMed ID: 29779026 [Abstract] [Full Text] [Related]
20. Prevalence of non-diabetic kidney disease and inability of clinical predictors to differentiate it from diabetic kidney disease: results from a prospectively performed renal biopsy study. Basu M, Pulai S, Neogi S, Banerjee M, Bhattacharyya NP, Sengupta S, Mukhopadhyay P, Ray Chaudhury A, Ghosh S. BMJ Open Diabetes Res Care; 2022 Dec 24; 10(6):. PubMed ID: 36517108 [Abstract] [Full Text] [Related] Page: [Next] [New Search]